About us
Canada SageHerb Biotechnology Company Ltd. is an innovative biopharmaceutical company dedicated to advancing cell therapy and gene therapy technologies for clinical application. Based on rigorous scientific research and global collaboration, we focus on developing next-generation therapeutic solutions for severe, rare, and currently untreatable diseases.
As a high-tech enterprise in the life-science sector, our core mission is to make cutting-edge biotechnology safer, more effective, and more accessible to patients worldwide.
Pioneering Integration of Biotechnology and Traditional Herbal Science
In addition to our cell and gene therapy programs, Canada SageHerb has independently developed a series of patented traditional herbal technologies and formulations. These innovations are built upon modern pharmacology, molecular biology, and bioprocessing, transforming classical herbal wisdom into standardized, evidence-based biomedical products.
More importantly, we are one of the few companies globally exploring the synergistic integration of cell/gene therapy with traditional herbal bio-modulation technologies. Our research demonstrates that specific herbal-derived bioactive components can:
Enhance the viability and functional persistence of therapeutic cells
Improve cellular microenvironment conditions
Reduce treatment-related toxicity
Strengthen immune homeostasis and systemic tolerance
This pioneering combination aims to significantly improve the efficacy, safety, and long-term stability of advanced therapies.
Our Vision
Canada SageHerb is committed to integrating cutting-edge cell therapy and gene therapy platforms with the company’s proprietary and patented herbal bio-modulation technologies, creating a synergistic strategy that combines modern molecular intervention with traditional biological regulation.
We adopt an evidence-based and quantifiable research approach to systematically evaluate the potential of herbal components to enhance therapeutic cell function, improve vector safety, optimize the immune microenvironment, and extend the durability of clinical responses. This work progresses from in-vitro mechanistic studies to rigorous preclinical development and early-phase clinical translation.
Our Services
Gene Therapy R&D：
- AAV/CRISPR vector design, genome editing, and preclinical animal studies.
TCM Formulation：
Patent-based decoction optimization and small-molecule co-therapy.
AI-driven Drug Screening：
AI target prediction, virtual screening, and big-data analytics.
Clinical Trials & Regulatory：
- Clinical protocol design and regulatory filings with CFDA, EMA, USFDA
Technical Services：
process development, QC, and CMC technical support.
Industrialization Consulting：
- Incubation, fundraising coordination, and supply-chain integration consulting
IP Services：
- Patent drafting/maintenance, technology transfer, and licensing.
Technology & Products
Key platforms:
AAV/CRISPR vectors, patented TCM formula, AI screening engine.
Pipeline：
Pipeline: refractory oncology, rare genetic disorders, TCM-gene co-therapy.
